Topic: Rare cancers.
Destination: Rare cancers are traditionally understudied, reducing the progress of research and hindering decisions for patients, physicians, and policy makers. For many rare cancers, research to identify causes or develop strategies for prevention and early detection is extremely difficult. In addition, rare cancers can be extremely challenging in terms of diagnosis, getting information about the cancer and caregivers, fewer number of clinical trials, and lack of treatment options. The Rare Cancers Research Program (RCRP) is being launched by U.S. Congress to support research on the prevention, detection, diagnosis, and treatment of the Service members, Veterans, their families, and the American public.
At the stakeholders meeting it was decided that CDMRP will follow the definition of rare cancer as an incidence of six or fewer cases per 100,000 people per year.
Three awards are available:
• Concept Award (CA).
• Idea Development Award (IDA).
• Resource and Community Development Award (RCDA).
Budget: 100,000-600,000 USD, depending on the award mechanism.
Duration: 1-3 years.
• Concept Award (CA): July 18.
• Idea Development Award (IDA): June 22.
• Resource and Community Development Award (RCDA): June 22.
Llena el siguiente formulario para recibir más información: